Canadian startup Encycle Therapeutics nabs C$2.85 mln

Toronto-based drug discovery company Encycle Therapeutics has closed C$2.85 million in funding. The investors were Takeda Ventures Inc, Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. Encycle is a University of Toronto spin-out.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget